Prelude Therapeutics Incorporated Share Price
PRLDPrelude Therapeutics Incorporated Stock Performance
Open $1.89 | Prev. Close $2.27 | Circuit Range N/A |
Day Range $1.89 - $2.30 | Year Range $0.61 - $4.18 | Volume 38,793 |
Average Traded $2.15 |
Prelude Therapeutics Incorporated Share Price Chart
About Prelude Therapeutics Incorporated
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT3789, a selective degrader of SMARCA2 protein for the treatment of advanced or metastatic solid tumors with loss of SMARCA4 due to truncating mutation and/or deletion; PRT7732, a selective and orally bioavailable SMARCA2 degraders to treat advanced or metastatic solid tumors; and PRT2527, a cyclin-dependent kinase 9 inhibitor for the treatment of advanced solid tumors. The company's CDK9 program is a regulator of cancer-promoting transcriptional programs, including MCL1, MYC, and MYB. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.
Prelude Therapeutics Incorporated Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
22-Jan-26 | $1.89 | $2.23 | +0.00% |
22-Jan-26 | $1.89 | $2.23 | +21.20% |
21-Jan-26 | $1.95 | $1.84 | -0.27% |
20-Jan-26 | $1.84 | $1.84 | +1.93% |
16-Jan-26 | $2.09 | $1.81 | -15.81% |
15-Jan-26 | $2.17 | $2.15 | -3.59% |
14-Jan-26 | $2.18 | $2.23 | +0.45% |
FAQs on Prelude Therapeutics Incorporated Share Price
Can I buy Prelude Therapeutics Incorporated shares in India?
What is the share price of Prelude Therapeutics Incorporated?
What is the 5 year returns of Prelude Therapeutics Incorporated?
What are the high & low stock price of Prelude Therapeutics Incorporated today?
What is the 52-week high and low of Prelude Therapeutics Incorporated stock?